Mosnodenvir
N/A
Report date: 2024/03/19 15:35:34
NMEFirst In Class
Base Information
Drug NameMosnodenvir
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[12]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesJanssen Research & Development Llc
China Registration ClassN/A
Develop Information
Active CompaniesJanssen, LpNational Institute Of Allergy And Infectious Diseases (Niaid)Janssen Research & Development Llc
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A